Company Overview
About Neodocs
Neodocs is a Mumbai, India-based healthtech company — backed by Y Combinator (S21) with $2.48 million raised including a $2 million seed round in February 2024 led by Omidyar Network India with YC, 9Unicorns, Gemba Capital, Titan Capital, and 100Unicorns — providing instant at-home diagnostic test kits with proprietary biochemistry test cards that deliver visual color-change results for conditions including urinary tract infections, diabetes monitoring (HbA1c and glucose), kidney function (creatinine, protein), and general wellness panels without requiring any additional hardware beyond a smartphone camera. Founded in 2020, Neodocs has sold 200,000+ test cards used by 4,000+ doctors across India and has partnerships with major pharmaceutical companies including Cipla, Sun Pharma, and AstraZeneca for co-branded diagnostic test distribution.
Business Model & Competitive Advantage
Neodocs' smartphone-based diagnostic platform enables non-invasive point-of-care testing without the laboratory infrastructure typically required for biochemistry analysis: the Neodocs test card contains dried reagent pads that react colorimetrically with urine or other patient samples — the color change pattern indicates the concentration or presence of specific biomarkers. The Neodocs smartphone app uses the phone camera to capture the test card image, applies computer vision calibration algorithms to correct for lighting variations and camera differences, and interprets the color values against reference standards to generate quantitative results (not just positive/negative, but actual numerical values for glucose, creatinine, and other measurable analytes) within 5-10 minutes. The pharmaceutical partnerships (Cipla, Sun Pharma, Bayer, AstraZeneca, Eris Lifesciences) distribute Neodocs test cards through pharmacy channels alongside the chronic disease medications the tests monitor.
Competitive Landscape 2025–2026
In 2025, Neodocs competes in the point-of-care diagnostics, consumer health monitoring, and India at-home testing market with Siemens Healthineers (ETR: SHL, urinalysis strips and analyzers), Abbvie's Abbott Diagnostics (NYSE: ABT, point-of-care testing), and domestic India diagnostic kit manufacturers for diabetes and chronic disease monitoring test distribution. India's 77 million+ diagnosed diabetics (the world's second-largest diabetic population) and estimated 40 million+ UTI cases annually create structural demand for affordable, accessible point-of-care monitoring. Neodocs' pharmaceutical distribution partnerships (riding Cipla and Sun Pharma's pharmacy networks) provide reach into 800,000+ Indian pharmacies that no direct consumer channel could replicate at comparable speed. Omidyar Network India's impact investment thesis aligns with Neodocs' health access mission for India's Tier 2-4 city population. The 2025 strategy focuses on growing the doctor prescription/recommendation channel, expanding the test panel to thyroid and liver function, and building the longitudinal health data platform for chronic disease management.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Neodocs is an emerging player bringing innovative solutions to the Healthcare market.
Frequently Asked Questions
AI Visibility Rankings
How Neodocs performs in AI search results
Unlock AI Visibility Tracking for Neodocs
See exactly how Neodocs ranks across ChatGPT, Gemini, Perplexity, Claude, and Grok. Get actionable insights to improve your AI search performance.
Join 1,000+ brands · Free 7-day trial · No credit card required
Not So Random Others
Cradle
Cradle is a protein design platform using AI to help biotechnology and pharmaceutical companies engineer better proteins — enzymes, antibodies, and therapeutic proteins — with improved stability, acti
Benchling
Benchling is a cloud-based research and development platform purpose-built for the life sciences industry, founded in 2012 by Sajith Wickramasekara and Ashu Singhal as a Y Combinator alumnus. The comp
In-N-Out Burger
In-N-Out Burger is a privately held American regional fast-food chain founded in 1948 by Harry and Esther Snyder in Baldwin Park, California. The company is entirely family-owned, with no franchises,
Tropicana
Tropicana is one of the world's most recognized orange juice brands, offering not-from-concentrate, freshly squeezed, and juice blend products in refrigerated and shelf-stable formats across North Ame
Camden Property Trust
Camden Property Trust is a Houston, Texas-based apartment REIT (Real Estate Investment Trust) — publicly traded on the New York Stock Exchange (NYSE: CPT) as an S&P 500 Real Estate component — owning,
Culver's
Culver's is a Prairie du Sac, Wisconsin-based fast-food chain — privately owned and operated by Culver Franchising System, LLC — specializing in ButterBurgers (fresh never-frozen beef patties cooked t
Compare Neodocs with Competitors
See how Neodocs stacks up against competitors in Healthcare with side-by-side revenue, market share, and AI visibility data.
Start ComparisonTrack Neodocs's AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Neodocs. Get alerts when AI recommendations change. See competitive intelligence across all AI platforms.